Drug Profile
Alendronic acid topical - Tritech Biopharmaceuticals
Alternative Names: Topical alendronate - Tritech Biopharmaceuticals; TR-563Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Tritech Biopharmaceuticals
- Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
- Mechanism of Action Osteoclast inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for preclinical development in Osteoporosis in Taiwan (Topical)
- 24 Jan 2019 Preclinical trials in Osteoporosis in Taiwan (Topical) before January 2019 (Tritech Biopharmaceuticals pipeline, January 2019)
- 19 Apr 2017 Early research in Osteoporosis in Taiwan (Topical) prior to April 2017 (Tritech Biopharmaceuticals pipeline, April 2017)